D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 77 Citations 23,883 208 World Ranking 369 National Ranking 189
Medicine D-index 80 Citations 25,127 225 World Ranking 9503 National Ranking 5139

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Acquired immunodeficiency syndrome

Robert W. Shafer mostly deals with Virology, Drug resistance, Reverse transcriptase, Genetics and Immunology. His study in Virus, Zidovudine, Reverse-transcriptase inhibitor, Didanosine and Lamivudine falls within the category of Virology. His study in Drug resistance is interdisciplinary in nature, drawing from both Mutation, Viral disease, Protease, HIV drug resistance and Genotype.

His work in Reverse transcriptase addresses issues such as Multiple drug resistance, which are connected to fields such as Mutagenesis. His work deals with themes such as Computational biology and Genetic diversity, which intersect with Genetics. The concepts of his Immunology study are interwoven with issues in Randomized controlled trial and Genome-wide association study.

His most cited work include:

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation (910 citations)
  • Human immunodeficiency virus reverse transcriptase and protease sequence database (728 citations)
  • Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update (707 citations)

What are the main themes of his work throughout his whole career to date?

Virology, Drug resistance, Genetics, Reverse transcriptase and Virus are his primary areas of study. His Virology study combines topics in areas such as Mutation, Protease and Genotype. His Drug resistance study integrates concerns from other disciplines, such as Regimen, Acquired immunodeficiency syndrome, Immunology, HIV drug resistance and Resistance mutation.

His Immunology research is multidisciplinary, relying on both Internal medicine and Drug. Robert W. Shafer combines subjects such as Molecular biology, Nucleic acid sequence and Zidovudine with his study of Reverse transcriptase. The study incorporates disciplines such as RNA, Nucleotidyltransferase and Polymerase chain reaction in addition to Virus.

He most often published in these fields:

  • Virology (50.34%)
  • Drug resistance (40.34%)
  • Genetics (25.86%)

What were the highlights of his more recent work (between 2015-2021)?

  • Drug resistance (40.34%)
  • Virology (50.34%)
  • Mutation (15.86%)

In recent papers he was focusing on the following fields of study:

His main research concerns Drug resistance, Virology, Mutation, HIV drug resistance and Antiretroviral therapy. The Drug resistance study combines topics in areas such as Integrase, Regimen, Reverse transcriptase and Intensive care medicine. His Virology study incorporates themes from Polymerase, Clinical trial, Integrase inhibitor, Genotype and Monoclonal antibody.

To a larger extent, he studies Genetics with the aim of understanding Mutation. His Genetics study often links to related topics such as Protease. As a part of the same scientific family, he mostly works in the field of HIV drug resistance, focusing on Epidemiology and, on occasion, Incidence.

Between 2015 and 2021, his most popular works were:

  • Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study (153 citations)
  • HIV-1 drug resistance and resistance testing (117 citations)
  • 2017 Update of the Drug Resistance Mutations in HIV-1. (116 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Acquired immunodeficiency syndrome

Robert W. Shafer mainly focuses on Drug resistance, Virology, Reverse transcriptase, Regimen and Intensive care medicine. The various areas that Robert W. Shafer examines in his Drug resistance study include Mutation, Acquired immunodeficiency syndrome, Reverse-transcriptase inhibitor, Transmission and HIV drug resistance. His Mutation study is related to the wider topic of Genetics.

His Virology research is multidisciplinary, relying on both Genotypic resistance and Genotype. He interconnects Sanger sequencing, Molecular epidemiology, Integrase and Odds ratio in the investigation of issues within Reverse transcriptase. His Internal medicine research incorporates elements of Treatment as prevention and Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

Pereyra F;Jia X;McLaren Pj.
Science (2010)

1350 Citations

2011 update of the drug resistance mutations in HIV-1.

V A Johnson;Calvez;H F Gunthard;R Paredes.
Topics in antiviral medicine (2011)

1225 Citations

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes.
PLOS ONE (2009)

992 Citations

Human immunodeficiency virus reverse transcriptase and protease sequence database

Robert W. Shafer;Derek Stevenson;Bryan Chan.
Nucleic Acids Research (1999)

834 Citations

2017 Update of the Drug Resistance Mutations in HIV-1.

Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson.
Topics in antiviral medicine (2016)

770 Citations

2015 Update of the Drug Resistance Mutations in HIV-1.

Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson.
Topics in antiviral medicine (2015)

758 Citations

2014 Update of the drug resistance mutations in HIV-1.

Annemarie M Wensing;Vincent Calvez;Huldrych F Günthard;Victoria A Johnson.
Topics in antiviral medicine (2014)

757 Citations

Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection.

Peter M. Small;Robert W. Shafer;Philip C. Hopewell;Samir P. Singh.
The New England Journal of Medicine (1993)

743 Citations

Web resources for HIV type 1 genotypic-resistance test interpretation.

Tommy F. Liu;Robert W. Shafer.
Clinical Infectious Diseases (2006)

575 Citations

Characterization of mutation spectra with ultra-deep pyrosequencing: Application to HIV-1 drug resistance

Chunlin Wang;Yumi Mitsuya;Baback Gharizadeh;Mostafa Ronaghi.
Genome Research (2007)

516 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robert W. Shafer

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 159

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 145

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 117

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 94

Eric Delwart

Eric Delwart

University of California, San Francisco

Publications: 93

Deenan Pillay

Deenan Pillay

University College London

Publications: 91

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 88

Daniel R. Kuritzkes

Daniel R. Kuritzkes

Brigham and Women's Hospital

Publications: 84

Carlo Federico Perno

Carlo Federico Perno

University of Milan

Publications: 83

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 81

Zabrina L. Brumme

Zabrina L. Brumme

Simon Fraser University

Publications: 80

David W. Haas

David W. Haas

Vanderbilt University

Publications: 77

Davey M. Smith

Davey M. Smith

University of California, San Diego

Publications: 71

Mary Carrington

Mary Carrington

Ragon Institute of MGH, MIT and Harvard

Publications: 69

David Katzenstein

David Katzenstein

Stanford University

Publications: 66

Anders Sönnerborg

Anders Sönnerborg

Karolinska Institute

Publications: 66

Something went wrong. Please try again later.